Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study.
Artikel i vetenskaplig tidskrift, 2010

Chronic heart failure with normal left ventricular ejection fraction (HFNEF) is not only common, but also carries a high risk of substantial morbidity and mortality. However, few studies have been conducted in this population and no proven treatment is available. Although beta-blockers are evidence-based first-line therapy in systolic heart failure, they have not been well studied in HFNEF.

Författare

Jingmin Zhou

Haiming Shi

Yongxin Lu

Michael Fu

Göteborgs universitet

Junbo Ge

European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology

1879-0844 (ISSN)

Vol. 12 181-5

Ämneskategorier

MEDICIN OCH HÄLSOVETENSKAP

Kardiologi

DOI

10.1093/eurjhf/hfp193

PubMed

20083625